A regular or an intermittent treatment for asthma: The long-term effect

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 12, 2010, Pages 1037-1044

  Sposato, Bruno ^a   Pammolli, A ^b   Bove, L ^a   Barzan, R ^a   Ricci, A ^c   Scalese, M ^d   Mariotta, S ^c   Franco, C ^a  

^a MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d CNR   (Italy)

Author keywords

Asthma; Decline; FEV; Inhaled corticosteroids; Intermittent therapy; Lung function decline; Regular therapy

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE; BRONCHODILATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; MONTELUKAST; SALMETEROL; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG DOSE REGIMEN; EXPIRATORY RESERVE VOLUME; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BRONCHODILATOR AGENTS; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; ITALY; LUNG; MALE; MAXIMAL MIDEXPIRATORY FLOW RATE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPIROMETRY; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 79951843018     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. GINA INTERNATIONAL GUIDELINES. Update 2007. www.ginasthma.org.
2. NATIONAL HEART, LUNG AND BLOOD INSTITUTE. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma; 2007. http://www.nhlbi.nih.gov/guidelines/asthma/.
3. LANGE P, PARNER J, VESTBO J, SCHNOHR P JENSEN G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-200.
4. DOMPELING E, VAN SCHAYCK CP, VAN GRUNSVEN PM, VAN HERWAARDEN CL, AKKERMANS R, MOLEMA J, FOLGERING H, VAN WEEL C. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study. Ann Intern Med 1993; 118: 770-778.
5. KUPCZYK M, KUPRYS I, GORSKI P, KUNA P. Long-term deterioration of lung function in asthmatic outpatients. Respiration 2004; 71: 233-240.
6. CIBELLA F, CUTTITTA G, BELLIA V, BUCCHIERI S, D'ANNA S, GUERRERA D, BONSIGNORE G. Lung function decline in bronchial asthma. Chest 2002; 122: 1944-1948.
7. O'BYRNE PM, PEDERSEN S, LAMM CJ, TAN WC, BUSSE WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009; 179: 19-24.
8. LANGE P, SCHARLING H, ULRIK CS, VESTBO J. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006; 61: 100-104.
9. DIJKSTRA A, VONK JM, JONGEPIER H, KOPPELMAN GH, SCHOUTEN JP, TEN HACKEN NHT, TIMENS W, POSTMA DS. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 2006; 61: 105-110.
10. DE MARCO R, MARCON A, JARVIS D, ACCORDINI S, BUGIANI M, CAZZOLETTI L, CERVERI I, CORSICO A, GISLASON D, GULSVIK A, JOGI R, MARTINEZ-MORATALLA J, PIN I, JANSON C; ECRHS THERAPY GROUP. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol 2007; 119: 611-617.
11. O'BYRNE PM, LAMM CJ, BUSSE WW, TAN WC, PEDERSEN S; START INVESTIGATORS GROUP. The effect of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma. Chest 2009; 136: 1514-1520.
12. FUHRMAN C, ERNST P, KAUFFMANN F. Long-term effects of therapy on respiratory health. Eur Respir J 1996; 9: 436-443.
13. GILLISEN A. Patient's adherence in asthma. J Physiol Pharmacol 2007; 58: 205-222
14. KAISER HB. Compliance and noncompliance in asthma. Allergy Asthma Proc 2007; 28: 514-516.
15. BOUSHEY HA, SORKNESS CA, KING TS, SULLIVAN SD, FAHY JV, LAZARUS SC, CHINCHILLI VM, CRAIG TJ, DIMANGO EA, DEYKIN A, FAGAN JK, FISH JE, FORD JG, KRAFT M, LEMANSKE RF JR, LEONE FT, MARTIN RJ, MAUGER EA, PESOLA GR, PETERS SP, ROLLINGS NJ, SZEFLER SJ, WECHSLER ME, ISRAEL E, NATIONAL HEART, LUNG AND BLOOD INSTITUTE'S ASTHMA CLINICAL RESEARCH NETWORK. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med 2005; 352: 1519-1528.
16. O'BYRNE PM, BARNES PJ, RODRIGUEZ-ROISIN R, RUNNERSTROM E, SANDSTROM T, SVENSSON K, TATTERSFIELD A. Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 2001; 164: 1392-1397.
17. THE AMERICAN LUNG ASSOCIATION ASTHMA CLINICAL RESEARCH CENTERS. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007; 356: 2027-2039.
18. HAAHTELA T, JARVINEN M, KAVA T, KIVIRANTA K, KOSKINEN S, LEHTONEN K, NIKANDER K, PERSSON T, SELROOS O, SOVIJÄRVI A, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.
19. PAUWELS RA, PEDERSEN S, BUSSE WW, TAN WC, CHEN YZ, OHLSSON SV, ULLMAN A, LAMM CJ, O'BYRNE PM; START INVESTIGATORS GROUP. Early intervention with budesonide in mild persistent asthma: a randomized double blind trial. Lancet 2003; 361: 1071-1076.
20. BUSSE WW, PEDERSEN S, PAUWELS RA, TAN WC, CHEN Y, LAMM CJ, O'BYRNE PM. The inhaled steroid treatment as regular therapy in early asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma. J Allergy Clin Immunol 2008; 121: 1167-1174.
21. KOENIG SM, OSTROM N, PEARLMAN D, WAITKUS-EDWARDS K, YANCEY S, PRILLAMAN BA, DORINSKY P. Deterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped- down". J Asthma 2008; 45: 681-687.
22. TURPEINEN M, NIKANDER K, PELKONEN AS, SYVANEN P, SORVA R, RAITIO H, MALMBERG P, JUNTUNEN-BACKMAN K, HAAHTELA T. Daily versus as-needed inhaled corticosteroids for mild persistent asthma (The Helsinky early intervention childhood asthma study). Arch Dis Child 2008; 93: 654-659.
23. HASEGAWA H, INUI N, FUJISAWA T, SATO J, NAKAMURA H, WATANABE H, SUDA T, CHIDA K. Once-daily inhaled glucocorticosteroid administration in controlled asthma patients. Pulm Pharmacol Ther 2008; 21: 663-667.
24. FAHY JV, BOUSHEY HA. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J 1998; 11: 1240-1247.
25. STRUNK RC, STERNBERG AL, SZEFLER SJ, ZEIGER RS, BENDER B, TONASCIA J; CHILDOOD ASTHMA MANAGEMENT PROGRAM (CAMP) RESEARCH GROUP. Long-term budesonide or nedocromil treatment, once discontinued, does not alter the course of mild to moderate asthma in children and adolescents. J Pediatr 2009; 154: 682-687.
26. THE CHILDOOD ASTHMA MANAGEMENT PROGRAM RESEARCH GROUP. Long-term effects of budesonide or nedocromil in chidren with asthma. N Engl J Med 2000; 343: 1054-1063.
27. DEN OTTER JJ, VAN SCHAYCK CP, FOLGERING HT, VAN DEN BOOM G, AKKERMANS RP, VAN WEEL C. Early intervention with inhaled corticosteroids in subjects with rapid decline in lung function and signs of bronchial hyperresponsiveness: results from the DIMCA programme. Eur J Gen Pract 2007; 13: 89-91.
28. PASCUAL RM, PETERS SP. The irreversible component of persistent asthma. J Allergy Clin Immunol 2009; 124: 883-890.
29. PANETTIERI RA JR, COVAR RA, GRANT E, HILLYER EV, BACHARIER L. Natural history of asthma: persistence versus progression-does the beginning predict the end? J Allergy Clin Immunol 2008; 121: 607-613.
30. BJERMER L. History and future perspectives of treating asthma as a systemic and small airways disease. Respir Med 2001; 95: 703-719.
31. HAMID Q, SONG Y, KOTSIMBOS TC, MINSHALL E, BAIR TR, HEGELE RG, HOGG JC. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997; 100: 44-51.
32. HAUBER HP, GOTFRIED M, NEWMAN K, DANDA R, SERVI RJ, CHRISTODOULOPOULOS P, HAMID Q. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003; 112: 58-63.
33. YAMAGUCHI M, NIIMI A, UEDA T, TAKEMURA M, MATSUOKA H, JINNAI M, OTSUKA K, OGUMA T, TAKEDA T, ITO I, MATSUMOTO H, HIRAI T, CHIN K, MISHIMA M. Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry. PuIm Pharmacol Ther 2009; 22: 326-332.
34. TASHKIN DP. The role of small airway inflammation in asthma. Allergy Asthma Proc 2002; 23: 233-242.